Macugen (pegaptanib sodium)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Macugen (pegaptanib sodium), covering 2014-03-05 to 2014-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy [Phase 3]